Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial

Autor: Raggi, Paolo, Bellasi, Antonio, Sinha, Smeeta, Bover, Jordi, Rodriguez, Mariano, Ketteler, Markus, Bushinsky, David A., Garg, Rekha, Perelló, Joan, Gold, Alex, Chertow, Glenn M.
Zdroj: In Kidney International Reports December 2020 5(12):2178-2182
Databáze: ScienceDirect